Related Experiment Video
Updated: Nov 14, 2025

10:17
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
10.0K
Implementation of a Universal Screening Process for Substance Use in Pregnancy
Micah Ulrich1, Elise Petersen Memmo, Alissa Cruz
1Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
Obstetrics and Gynecology
|March 11, 2021
Summary
Implementing universal substance use screening in prenatal care is feasible, identifying at-risk patients. Sustaining documentation of brief interventions for positive screens requires further effort.
Area of Science:
- Obstetrics and Gynecology
- Public Health
- Healthcare Quality Improvement
Background:
- Substance use during pregnancy poses significant risks to both mother and child.
- Standardized screening processes are crucial for early identification and intervention in prenatal care settings.
- Existing screening methods may not be universally applied in diverse clinical environments.
Purpose of the Study:
- To implement and evaluate a standardized universal substance use screening process for prenatal patients.
- To assess the feasibility and effectiveness of integrating the 5Ps screening tool and SBIRT model into routine prenatal care.
- To measure the rates of screening completion, positive screens, and subsequent interventions.
Main Methods:
- A quality-improvement framework utilizing process modeling and plan-do-study-act cycles was employed.
- A modified 5Ps (Parents, Peers, Partner, Past, Present) screening tool was adapted for universal use.
- The Screening, Brief Intervention, Referral to Treatment (SBIRT) model guided the intervention workflow.
Main Results:
- A substance use screen was completed in 84% of 733 patient encounters over 19 months.
- Screening rates exceeded the 90% goal in the final six months of data collection.
- 20% of screened patients tested positive, with intervention documentation reaching 80% initially but declining to 50%.
Conclusions:
- A sustainable and generalizable universal substance use screening process is achievable in large prenatal clinics.
- The screening process successfully identified patients not previously known to be at risk.
- Sustaining healthcare practitioner documentation of interventions for positive screens remains a challenge requiring further investigation.

